– 2020 Guidance of $230 Million to $245 Million in Revenues and $0.60 to $0.75 in Earnings Per Share — Anticipated ENHANZE® Partner Progress in 2020 Includes At Least One Potential FDA Approval, Three New Phase 3, One New Phase 2 and Five New Phase 1 … […]
SAN DIEGO, Jan. 13, 2020 /PRNewswire/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today the appointment of Joan Schmidt as Executive Vice President, General Counsel and Secretary. Ms. Schmidt will join Arena formally in March 20… […]
MADISON, Wis., Nov. 26, 2019 /PRNewswire/ — Terso Solutions, the leading provider of automated inventory management solutions for tracking high-value medical and scientific products in healthcare and life science, announced today it will be exhibit… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
